Respiratory disease companies develop therapies, diagnostics and research technologies for conditions affecting the lungs and airways. Their work supports earlier detection, improved disease monitoring and the development of treatments for acute, chronic and inherited pulmonary disorders.
This category includes companies working on:
Browse 65 UK respiratory disease companies below.
Bacillus spore-based vaccines, drug delivery and probiotic therapeutics developer
SporeGen is a biotechnology company working exclusively on spore-forming Bacillus bacteria to develop vaccines, drug delivery platforms and probiotic therapeutics. The company's…
Broad-spectrum intranasal antivirals targeting respiratory viral infections
Pneumagen is a Scottish clinical-stage biotechnology company developing broad-spectrum intranasal antiviral therapies. Pneumagen’s platform generates multivalent carbohydrate…
Engineered macrophage cell therapy for inflammatory and fibrotic disease
Resolution Therapeutics is a clinical-stage biotech developing regenerative macrophage therapies for inflammatory and fibrotic diseases. Its platform harnesses the…
Programmable RNA delivery platform targeting non-hepatic tissues
Sixfold Bioscience is a biotechnology company developing a programmable RNA-based delivery platform that exploits the body's natural extracellular RNA transport pathways to direct…
Active protease biomarker assays for respiratory disease diagnostics
ProAxsis is a diagnostics company developing and supplying laboratory immunoassays and point-of-care tests for the measurement of active protease biomarkers in respiratory…
Preclinical therapeutic company targeting tissue fibrosis in allergic asthma
Fibraxis is a preclinical-stage biotechnology company developing a therapeutic for allergic asthma that targets tissue fibrosis in the lung. Spun out of Aston University and…
Aerosol technology for inhaled drug formulation development
Microsol is a Bristol-based technology company developing advanced measurement and computational tools for aerosol characterisation in respiratory drug delivery. Its platform…
Multiomics blood-based platform for early-stage cancer detection
Freenome is a biotechnology company developing blood-based early cancer detection tests using a multiomics platform that combines tumour and non-tumour biological signals with…
Point-of-care molecular diagnostic platform for rapid infectious disease detection
Diagnostics for the Real World (Europe) is a Cambridge University spin-out developing and commercialising a fully automated point-of-care molecular diagnostic system for rapid…
Specialist respiratory CRO delivering human challenge trials and preclinical models
Virtus Respiratory Research is a contract research organisation specialising in early-stage clinical and preclinical research for respiratory drug development. The company…
Clinical-stage anti-infectives targeting antimicrobial resistance and infectious disease
NovaBiotics is a clinical-stage biotechnology company developing first-in-class anti-infective therapies for difficult-to-treat infectious diseases, with a focus on antimicrobial…
Generic, branded and biosimilar medicines across global therapeutic areas
Viatris UK Healthcare is the UK subsidiary of Viatris Inc., a global pharmaceutical company formed in 2020 through the combination of Mylan and Pfizer's Upjohn division. Operating…